Statistics for Utah Medical Products (id:8113 UTMD)
Valuation metrics
Market cap
227.25M
Enterprise value
140.71M
Trailing P/E (ttm)
15.43
Forward P/E
PEG ratio
Price/Sales (ttm)
5.16
Price/Book (mrq)
1.83
Enterprise Value/Revenue
3.19
Enterprise Value/EBITDA
6.99
Overview
Shares outstanding
3.44M
Float
2.98M
Shares short
56.80K
% Held by insiders
0.07%
% Held by institutions
0.74%
Average volume (10 days)
30.25K
Average volume (90 days)
Price summary
52-Week low
63.38
52-Week high
87.21
52-Week change
-28.08%
Beta
0.08
50-Day moving average
66.03
200-Day moving average
68.25
Dividends and splits
Forward annual dividend rate
1.20
Forward annual dividend yield
0.02
Trailing annual dividend rate
1.20%
Trailing annual dividend yield
0.02
5-Year annual dividend yield
1.31
Payout ratio
0.28
Dividend date
October 04th, 2024
Ex-dividend date
December 16th, 2024
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31th, 2023
Most recent quarter (mrq)
September 30th, 2024
Profitability
Profit margin
34.62%
Operating margin
37.54%
Operational effectiveness
Return on assets
8.18%
Return on equity
12.31%
Income statement
Revenue (ttm)
12.39
Revenue per share (ttm)
12.39
Quarterly revenue growth (yoy)
-0.09
Gross profit (ttm)
30.04M
EBITDA
19.25M
Net income to common (ttm)
15.26M
Diluted EPS (ttm)
4.28
Quarterly earnings growth (yoy)
-9.40%
Balance sheet
Total cash (mrq)
88.45M
Total cash per share (mrq)
25.71
Total debt (mrq)
299.00K
Total Debt/Equity (mrq)
0.24
Current ratio (mrq)
2.96K%
Book value per share (mrq)
36.10
Cash flow
Cash flow statement
23.69M
Levered free cash flow (LFCF)
16.64M